Corporate News     09-Jan-20
Solara Active Pharma Sciences update on Nizatidine Capsules
Solara Active Pharma Sciences announced the company understands from Mylan NVs press release dated 08 January 2020 that Mylan N.V.'s U.S. based Mylan Pharmaceuticals(Mylan) has initiated a voluntary recall of three lots of Nizatidine Capsules, USP (150mg and 300mg strengths) due to detected trace amounts of impurity Nnitrosodimethylamine (NOMA) contained in the Nizatidine APL Mylan also indicated that the recall is voluntary, and the Company has not received any reports of adverse events related to these batches to date.

The company is in the process of collecting corresponding lots of API from Mylan to carry out its own internal investigation.

The company's last supplies of Nizatidine API to Mylan were made in September 2017 and the company's overall sales of this API to the US market are less than 0.1 % of total company revenues.

Previous News
  Solara Active Pharma Sciences reports consolidated net loss of Rs 9.96 crore in the September 2022 quarter
 ( Results - Announcements 09-Nov-22   15:07 )
  Volumes spurt at Sudarshan Chemical Industries Ltd counter
 ( Hot Pursuit - 08-Jul-22   14:30 )
  Solara Active Pharma Sciences announces change in CFO
 ( Corporate News - 09-Mar-22   19:05 )
  Solara Active Pharma Sciences announces resignation of director
 ( Corporate News - 04-Aug-22   16:28 )
  Solara Active Pharma Sciences schedules board meeting
 ( Corporate News - 20-Jan-23   10:49 )
  Solara Active Pharma Sciences to table results
 ( Corporate News - 06-Feb-24   17:03 )
  Subex Ltd leads losers in 'A' group
 ( Hot Pursuit - 15-May-23   15:00 )
  Solara Active Pharma Sciences finalizes terms of proposed rights issue
 ( Corporate News - 10-May-24   09:23 )
  Solara Active Pharma Sciences acquires additional stake in Sequent Penems
 ( Corporate News - 28-Apr-21   17:42 )
  Solara Active Pharma Sciences reports consolidated net loss of Rs 255.34 crore in the March 2024 quarter
 ( Results - Announcements 29-May-24   17:02 )
  Solara Active Pharma Sciences to discuss results
 ( Corporate News - 28-Jan-20   17:10 )
Other Stories
  Optiemus showcases its high endurance Vajra 65 and Vajra 100 quadcopter drones
  07-Oct-24   20:12
  Bharat Electronics wins new orders of Rs 500 cr
  07-Oct-24   20:09
  Jaguar Land Rover records 3% drop in Q2 retail sales
  07-Oct-24   19:42
  Piccadily Agro launches limited edition Indri's 'City Series' for Bengaluru Duty Free
  07-Oct-24   19:39
  MOIL records best September production & sales
  07-Oct-24   19:37
  Electrosteel Castings acquires Singardo International
  07-Oct-24   19:30
  Avenue Supermarts to acquire 26% stake in FP Ampere Energy
  07-Oct-24   19:28
  Force Motors acquires 12.21% stake in TP Surya (SPV for solar power projects)
  07-Oct-24   19:09
  CreditAccess Grameen allots 3,614 equity shares under ESOP
  07-Oct-24   19:07
  Havells India allots 22,662 equity shares under ESPS
  07-Oct-24   19:04
Back Top